Carbohydrate markers of pancreatic cancer

Biochemical Society Transactions

Volumn 39, Issue 1, 2011, Pages 340-343

  Szajda, Sławomir Dariusz ^a   Waszkiewicz, Napoleon ^a   Chojnowska, Sylwia ^b   Zwierz, Krzysztof ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Institute of Physical Education   (Poland)

Author keywords

Carbohydrate antigen; Carbohydrate marker; Carcinoembryonic antigen; Diagnosis of cancer; Lysosomal exoglycosidase; Mucin; Pancreatic cancer

Indexed keywords

ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; BETA GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; CA 19-9 ANTIGEN; CA 242 ANTIGEN; CA 50 ANTIGEN; CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; GLYCOCONJUGATE; GLYCOSIDASE; MUCIN 1; MUCIN 2; MUCIN 5AC; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER RISK; CANCER SURVIVAL; CONFERENCE PAPER; EARLY DIAGNOSIS; HUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; GLYCOSIDE HYDROLASES; HUMANS; MALE; MUCINS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79551626900     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390340     Document Type: Conference Paper

References (38)

1. Lygidakis, N.J., Jain, S., Sacchi, M. and Vrachnos, P. (2005) Adenocarcinoma of the pancreas: past, present and future. Hepatogastroenterology 52, 1281-1292
2. Hariharan, D., Saied, A. and Kocher, H.M. (2008) Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 10, 58-62
3. Wojciechowska, U., Didkowska, J., Tarkowski, W. and Zatoński, W. (2005) Cancer in Poland in 2003, Institute of Oncology Press, Warsaw
4. Fargnoli, R. and Fusi, I. (1999) Computerized tomography of pancreatic tumors. Tumori 85 (Suppl. 1), S3-S5
5. Szajda, S.D., Jankowska, A. and Zwierz, K. (2008) Carbohydrate markers in colon carcinoma. Dis. Markers 25, 233-242
6. Vollmers, H.P. and Brändlein, S. (2007) Tumors: too sweet to remember? Mol. Cancer 6, 78
7. Tempero, M.A., Uchida, E., Takasaki, H., Burnett, D.A., Steplewski, Z. and Pour, P.M. (1987) Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res. 47, 5501-5503
8. Daram, S.R. (2006) CA 19-9: not a magic marker for pancreatic cancer. South. Med. J. 99, 205
9. Steinberg, W. (1990) The clinical utility of the CA 19-9 tumor-associated antigen. Am. J. Gastroenterol. 85, 350-355
10. Goggins, M. (2005) Molecular markers of early pancreatic cancer. J. Clin. Oncol. 23, 4524-4531
11. Duffy, M.J., Sturgeon, C., Lamerz, R., Haglund, C., Holubec, V.L., Klapdor, R., Nicolini, A., Topolcan, O. and Heinemann, V. (2010) Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann. Oncol. 21, 441-447
12. Duffy, M.J. (1998) CA 19-9 as a marker for gastrointestinal cancers. Ann. Clin. Biochem. 35, 364-370
13. Locker, G.Y., Hamilton, S., Harris, J., Jessup, J.M., Kemeny, N., Macdonald, J.S., Somerfield, M.R., Hayes, D.F. and Bast, Jr, R.C. (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24, 5313-5327
14. Bunworasate, U. and Voravud, N. (1995) CA 50: a tumor marker for gastrointestinal malignancies. J. Med. Assoc. Thai. 78, 255-270
15. Pålsson, B., Masson, P. and Andrén-Sandberg, A. (1997) Tumour marker CA 50 levels compared to signs and symptoms in the diagnosis of pancreatic cancer. Eur. J. Surg. Oncol. 23, 151-156
16. Soborczyk, A. and Deptała, A. (2007) Tumor markers in clinical practice. Choroby Serca i Naczyń 4, 184-189
17. Ozkan, H., Kaya, M. and Cengiz, A. (2003) Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Hepatogastroenterology. 50, 1669-1674
18. Haglund, C., Lundin, J., Kuusela, P. and Roberts, P.J. (1994) CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br. J. Cancer 70, 487-492
19. Liao, Q., Zhao, Y.P., Yang, Y.C., Li, L.J., Long, X. and Han, S.M. (2007) Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head. Hepatobiliary Pancreat Dis. Int. 6, 641-645
20. Yonezawa, S., Goto, M., Yamada, N., Higashi, M. and Nomoto, M. (2008) Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 8, 3329-3341
21. Hoimes, C.J., Moyer, M.T. and Saif, M.W. (2009) Biomarkers for early detection and screening in pancreatic cancer: highlights from the 45th ASCO Annual Meeting. Orlando, FL, USA. May 29-June 2, 2009. JOP 10, 352-356
22. Gold, D.V., Goggins, M., Modrak, D.E., Newsome, G., Liu, M., Shi, C., Hruban, R. and Goldenberg, D.M. (2010) Detection of early-stage pancreatic adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 19, 2786-2794
23. Gold, D.V., Goldenberg, D.M., Karacay, H., Rossi, E.A., Chang, C.H., Cardillo, T.M., McBride, W.J. and Sharkey, R.M. (2008) A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma. Cancer Res. 68, 4819-4826
24. Gold, D.V., Lew, K., Maliniak, R., Hernandez, M. and Cardillo, T. (1994) Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin. Int. J. Cancer. 15; 57, 204-210
25. Printz, C. (2010) Blood tests for protein biomarkers show promise. Cancer 116, 2505-2506
26. Gold, D.V., Karanjawala, Z., Modrak, D.E., Goldenberg, D.M. and Hruban, R.H. (2007) PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Clin. Cancer Res. 3, 7380-7387
27. Winchester, B. (2005) Lysosomal metabolism of glycoproteins. Glycobiology 15, 1R-15R
28. Moszczyński, P. and Lisiewicz, J. (1984) Deficiency of N-acetyl-β-D-glucosaminidase in neutrophils of cancer patients. J. Cancer Res. Clin. Oncol. 108, 243-245
29. Sułowicz, W., Lisiewicz, J., Kuźniewski, M. and Strzałka, H. (1985) Activity of some lysosomal enzymes in peripheral blood lymphocytes of patients with lung cancer. A cytochemical study. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch 112, 63-70
30. Skrzydlewska, E., Sulkowska, M., Koda, M. and Sulkowski, S. (2005) Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 11, 1251-1266
31. Kunishio, K., Okada, M., Matsumoto, Y. and Nagao, S. (2003) Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol. 20, 39-45
32. Szajda, S.D., Waszkiewicz, N., Stypułkowska, A., Dadan, J. and Zwierz, K. (2010) Lysosomal exoglycosidases in serum and urine of patients with pancreatic adenocarcinoma. Folia Histochem. Cytobiol. 48, 351-357
33. Szajda, S.D., Snarska, J., Jankowska, A., Puchalski, Z. and Zwierz, K. (2008) Isoenzymes A and B of N-acetyl-β-D-hexosaminidase in serum and urine of patients with pancreatic cancer. Hepatogastroenterology. 55, 695-698
34. Zwierz, P., Szajda, S.D., Snarska, J., Supronowicz, Z,B., Zawadzki, P., Zwierz, K. and Kamiński, F. (2006) Concentration of thyroid stimulating hormone and activity of N-acetyl-β-D-hexosaminidase and its isoenzymes, in serum of patients with thyroid cancer. Pol. Merkur. Lekarski 21, 439-442
35. Borzym-Kluczyk, M., Darewicz, B., Knaś, M., Szajda, S.D., Sulik, M., Olszewska, E. and Zwierz, K. (2005) The activity of N-acetyl-β- glucosaminidase and its isoenzymes in the renal tissue, serum and urine of patients with renal cancer. Contemp. Oncol. 9, 287-290
36. Borzym-Kluczyk, M., Olszewska, E., Szajda, S.D., Knaś, M., Darewicz, B. and Zwierz, K. (2006) Activity of isoenzymes A and B of N-acetyl-β-glucosaminidase in renal cancer tissue. Contemp. Oncol. 10, 502-505
37. Szajda, S.D., Borzym-Kluczyk, M., Snarska, J., Puchalski, Z. and Zwierz, K. (2009) N-acetyl-β-D-hexosaminidase and its isoenzymes A and B in blood serum and urine, as a potential colon cancer markers. Hepatogastroenterology 56, 1287-1298
38. Szajda, S.D., Snarska, J., Puchalski, Z. and Zwierz, K. (2008) Lysosomal exoglycosidases in serum and urine of patients with colon adenocarcinoma. Hepatogastroenterology 55, 921-925 (Pubitemid 351975956)